Detalhe da pesquisa
1.
Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapies.
Proc Natl Acad Sci U S A
; 118(30)2021 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34285073
2.
Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used.
Cancer Immunol Immunother
; 70(11): 3249-3258, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33835222
3.
Inhibition of collagen production delays malignant mesothelioma tumor growth in a murine model.
Biochem Biophys Res Commun
; 510(2): 198-204, 2019 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30685089
4.
Serial immunomonitoring of cancer patients receiving combined antagonistic anti-CD40 and chemotherapy reveals consistent and cyclical modulation of T cell and dendritic cell parameters.
BMC Cancer
; 17(1): 417, 2017 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28619093
5.
A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice.
BMC Cancer
; 17(1): 684, 2017 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29037232
6.
Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma.
BMC Cancer
; 17(1): 396, 2017 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28577549
7.
Calretinin as a blood-based biomarker for mesothelioma.
BMC Cancer
; 17(1): 386, 2017 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28558669
8.
Why we still need drugs for COVID-19 and can't just rely on vaccines.
Respirology
; 27(2): 109-111, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34970812
9.
Tumor-infiltrating dendritic cells exhibit defective cross-presentation of tumor antigens, but is reversed by chemotherapy.
Eur J Immunol
; 45(1): 49-59, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25316312
10.
Correction to: Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used.
Cancer Immunol Immunother
; 70(11): 3259, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34089374
11.
Erratum to: ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptoms.
Clin Proteomics
; 13: 3, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26903779
12.
ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptoms.
Clin Proteomics
; 13: 2, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26807072
13.
Immune response profiling of malignant pleural mesothelioma for diagnostic and prognostic biomarkers.
Biomarkers
; 21(6): 551-61, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27009350
14.
Immunotherapy for lung cancer.
Respirology
; 21(5): 821-33, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27101251
15.
Consistent gene expression profiles in MexTAg transgenic mouse and wild type mouse asbestos-induced mesothelioma.
BMC Cancer
; 15: 983, 2015 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-26680231
16.
Comparison of mesothelin and fibulin-3 in pleural fluid and serum as markers in malignant mesothelioma.
Curr Opin Pulm Med
; 21(4): 352-6, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26016578
17.
Asbestos in Asia.
Respirology
; 20(4): 548-55, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25819225
18.
Long-term exposure of mesothelial cells to SV40 and asbestos leads to malignant transformation and chemotherapy resistance.
Carcinogenesis
; 35(2): 407-14, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24130165
19.
Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma.
Thorax
; 69(10): 895-902, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25037982
20.
Neoadjuvant anti-tumor vaccination prior to surgery enhances survival.
J Transl Med
; 12: 245, 2014 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-25186961